At Genmab, we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

The Vice President, Medical Affairs Portfolio Evidence Strategy, will lead a dedicated team to execute Genmab’s comprehensive medical evidence generation strategy across all assets and therapeutic areas as well as ensure successful operational execution. This pivotal leadership role involves close collaboration with cross-functional teams across both Research & Development & Commercialization. Responsibilities include designing and conducting medical affairs-led studies, fostering collaborative research partnerships, developing disease and product registries, and ensuring Genmab’s investments in Phase 4 studies are strategically aligned, fulfill and unmet medical need and that execution of such studies are done in an efficient manner.

We have a hybrid model that requires being onsite 60% of the time in either Princeton, New Jersey; Copenhagen, Denmark; or Utrecht, Netherlands.

Responsibilities

Team Leadership and Development:

• Lead and develop a high-performing team to execute portfolio and asset-specific evidence generation strategies.

• Foster a culture of talent development, collaboration, innovation, and continuous learning within the team.

• Establishes a thriving culture for Medical Affairs, while contributing to the development of a high performing team

• Partner with Medical Affairs Leadership, Functional Heads, and internal subject matter experts to continuously monitor the external landscape and seek alternative approaches to improve current processes & ensure best practices and innovation are brought back into the organization.

Strategic Evidence Generation:

• Design and implement evidence generation activities to fill priority data gaps identified in portfolio or asset-specific Integrated Evidence Generation Plans (IEGPs) as part of the asset Medical Plans.

• Oversee the execution of a strategically aligned IEGP as part of the asset medical plan.

• Provide strategic input into the development of clinical trials and studies across the lifecycle to drive successful development and commercialization strategies.

External Engagement:

• Enable scientific engagement by cultivating and interacting with the broader scientific community to understand expertise across disease state experts and collaborative research networks.

• Collaborate with cross-functional teams, including Precision Medicine, Translational Research, Discovery, and Clinical, to drive evidence generation and differentiate our medicines.

Innovation and Operationalization:

• Build and optimize evidence generation capabilities to ensure operational success, budget management and timely delivery of Medical Affairs studies.

• Identify opportunities for innovation within the portfolio to address evidence gaps and enhance portfolio value.

• Develop and implement strategies to enhance operationalizing capabilities such as Investigator Initiated/Collaborative Studies, Real World Evidence, and Pre-Approval Access.

• Build relevant expertise within the team for these operational capabilities.

Stakeholder Engagement and Communication:

• Present medical evidence to internal and external stakeholders, including at scientific conferences and other relevant forums as needed.

• Serve as a delegate on concept and protocol review committees for company- and externally- sponsored research.

Requirements

• Advanced degree (MD, PhD, PharmD, or master’s degree in public health or related field) with at least 15 years of experience in the pharmaceutical industry; oncology experience is preferred.

• Extensive experience in designing and leading Medical Affairs research and collaborative studies.

• Proven leadership and team management abilities with previous experience and success in building high performing global teams influencing across multiple functions.

• Proven expertise in developing and maintaining disease and product registries.

• Strong knowledge and experience in Phase 4 study design and implementation.

• Excellent analytical and problem-solving skills with a data-driven approach to decision making.

• Capability to work independently while managing multiple projects simultaneously.

• Deep understanding of drug development processes with a strong track record of success.

• Strong interpersonal skills with the capability to effectively engage diverse stakeholders.

• Superior verbal and written communication and presentation skills.

• Proven ability to work collaboratively with cross-functional teams

For US based candidates, the proposed salary band for this position is as follows:

$288,750.00---$481,250.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as bonuses.

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. 

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website. 

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.